ABVC BioPharma, Inc. (ABVC) vs Seres Therapeutics, Inc. (MCRB)
ABVC BioPharma, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Seres Therapeutics, Inc. are of similar size ($36.0M and $34.0M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against −98.5%. ABVC BioPharma, Inc. has the higher net margin (0.00% vs −1,192.9%) and the higher return on invested capital (−33.5% vs −277.3%). Across the 17 metrics below, ABVC BioPharma, Inc. leads on 12 and Seres Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ABVC | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 100.00% | 65.16% |
| Operating margin | 0.00% | (4,462.77%) | 0.00% |
| Net margin | 0.00% | (1,192.94%) | 0.00% |
| Free cash flow margin | 0.00% | (2,721.83%) | 0.00% |
| Return on equity | (65.32%) | (66.57%) | (57.72%) |
| Return on assets | (39.88%) | (18.31%) | (49.22%) |
| Return on invested capital | (33.45%) | (277.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack